Commission Implementing Decision 2013/205/EU of 25 April 2013 allowing Member States to extend provisional authorisations granted for the new active substances acequinocyl, aminopyralid, ascorbic acid, flubendiamide, gamma-cyhalothrin, ipconazole, metaflumizone, orthosulfamuron, Pseudomonas sp. strain DSMZ 13134, pyridalil, pyroxsulam, spiromesifen, thiencarbazone and topramezone (notified under document C(2013) 2246)
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD) Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XV Dangerous Substances
Joint committee decision (JCD)
206/2014 In force in the EEA
Yes Legal documents
Commission Implementing Decision 2013/205/EU of 25 April 2013 allowing Member States to extend provisional authorisations granted for the new active substances acequinocyl, aminopyralid, ascorbic acid, flubendiamide, gamma-cyhalothrin, ipconazole, metaflumizone, orthosulfamuron, Pseudomonas sp. strain DSMZ 13134, pyridalil, pyroxsulam, spiromesifen, thiencarbazone and topramezone (notified under document C(2013) 2246)
Framkvæmdarákvörðun framkvæmdastjórnarinnar frá 25. apríl 2013 um að heimila aðildarríkjum að framlengja bráðabirgðaleyfi sem voru veitt fyrir nýju, virku efnunum asekínósýli, amínópýralíði, askorbínsýru, flúbendíamíði, gammasýhalótríni, ipkónasóli, metaflúmísóni, ortósúlfamúróni, Pseudomonas sp. af stofni DSMZ 13134, pýrídalíli, pýroxsúlami, spírómesífeni, þíenkarbasóni og tópramesóni (tilkynnt með númeri C(2013) 2246) (2013/205/ESB)
Durchführungsbeschluss der Kommission vom 25. April 2013 zur Ermächtigung der Mitgliedstaaten, vorläufige Zulassungen für die neuen Wirkstoffe Acequinocyl, Aminopyralid, Ascorbinsäure, Flubendiamid, gamma-Cyhalothrin, Ipconazol, Metaflumizon, Orthosulfamuron, Pseudomonas sp. Stamm DSMZ 13134, Pyridalil, Pyroxsulam, Spiromesifen, Thiencarbazon und Topramezon zu verlängern (2013/205/EU)
Kommisjonens gjennomføringsbeslutning av 25. april 2013 om tillatelse for medlemsstatene til å forlenge midlertidige godkjenninger gitt for de nye aktive stoffene acekinocyl, aminopyralid, askorbinsyre, flubendiamid, gammacyhalothrin, ipkonazol, metaflumizon, ortosulfamuron, Pseudomonas sp. stamme DSMZ 13134, pyridalil, pyroksulam, spiromesifen, tienkarbason og topramezon (2013/205/EU)
History
01.06.2015
Adopted JCD confirmed entry into force date
01.06.2015
Compliance date in the EEA
30.09.2014
Adoption of Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement
15.04.2014
Draft Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement sent to Commission
25.04.2013
Adoption date in the EU
15.05.2013
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.